<DOC>
	<DOCNO>NCT00363194</DOCNO>
	<brief_summary>This two-part study ( Part I/Part II ) . Part I design determine effect low high fat meal pharmacokinetics single dose pazopanib ( GW572016 ) . Part II design allow patient continue access study drug multiple dose regimen . Patients receive clinical benefit regimen go long term rollover study VEG105430 provide stable 8 week .</brief_summary>
	<brief_title>A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Confirmed advance solid tumor ( ) Must adequate blood , liver , kidney function . Must willing abstain intercourse 2 week prior administration first dose study medication 28 day final dose study medication willing consistently correctly use acceptable method birth control . Exclusion criterion : Patients certain heart problem history bleed within month .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Pazopanib GW786034 Advanced cancer Metastatic cancer</keyword>
</DOC>